Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

ATXS Astria Therapeutics Inc

9,65

0,31 (3,32%)

22 Nov 2024 - Fechado

Atrasado em 15 minutos

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Astria Therapeutics (NASDAQ:ATXS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024

Click aqui para mais gráficos Astria Therapeutics.

Astria Therapeutics (NASDAQ:ATXS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024

Click aqui para mais gráficos Astria Therapeutics.

Notícias Astria Therapeutics Inc

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quinta, 14 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quinta, 14 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Quinta, 14 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quarta, 13 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Quarta, 13 de Novembro de 2024 (2 semanas atrás) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Quarta, 13 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
Quarta, 13 de Novembro de 2024 (2 semanas atrás) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sexta, 8 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Segunda, 4 de Novembro de 2024 (3 semanas atrás) • Business Wire

Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
Quarta, 30 de Outubro de 2024 (4 semanas atrás) • Business Wire

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
Segunda, 21 de Outubro de 2024 (1 mês atrás) • Business Wire

European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics’ Investigational Therapy for the Treatment of Hereditary Angioedema
Quarta, 16 de Outubro de 2024 (1 mês atrás) • Business Wire

Mais Notícias de Astria Therapeutics Inc

Índice Bovespa

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições